+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immuno Oncology Assays Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2019 Update)

  • ID: 4763781
  • Report
  • Region: Global
  • 156 pages
  • 360iResearch
1 of 5

FEATURED COMPANIES

  • Foundation Medicine
  • Illumina, Inc.
  • Merck
  • Perkinelmer
  • Qiagen
  • Roche Diagnostics
  • MORE
The global immuno oncology assays market is expected to grow from USD 2.47 billion in 2017 to USD 5.43 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 11.95%.

“Growing incidences of cancer
is one of the factors largely attributing to the growth of immuno oncology assays market globally”

The factors attributing to the growth of the market are growing incidences of cancer, adoption of targeted therapy over other treatment options, development of bioinformatic tools enhancing the drug development process, rise in healthcare expenditure and healthcare insurance, and technological advancement and r&d for the treatment of cancer. However, some factors such as and unfavorable regulatory and reimbursement scenario may hinder the market growth. The global immuno oncology assays market is expected to showcase the opportunities such as clinical trials to cure different cancers in immunotherapy, and companion diagnostics have the potential to improve immunotherapy efficacy and ensure greater safety. In the near future market may face the possible challenges in the growth due to and cancer limiting the immune response. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global immuno oncology assays market.

“Lung Cancer: The highest growing indication for the global immuno oncology assays market”

On the basis of indication, the global immuno oncology assays market is studied across Bladder Cancer, Colorectal Cancer, Lung Cancer, and Melanoma. Among all these indication, the Lung Cancer is projected to hold the largest market share while the Melanoma has the potential to grow the market with the highest CAGR in the forecast period.

“Consumables: The highest growing product for the global immuno oncology assays market”

On the basis of product, the global immuno oncology assays market is studied across Consumables and Software. Among all these product, the Consumables is projected to hold the largest market share while the Consumables has the potential to grow the market with the highest CAGR in the forecast period.

“Immunoassay: The highest growing technology for the global immuno oncology assays market”

On the basis of technology, the global immuno oncology assays market is studied across Flow Cytometry, Immunoassay, Ngs, and PCR. Among all these technology, the Immunoassay is projected to hold the largest market share while the Immunoassay has the potential to grow the market with the highest CAGR in the forecast period.

“Research: The highest growing application for the global immuno oncology assays market”

On the basis of application, the global immuno oncology assays market is studied across Clinical Diagnostics and Research. Among all these application, the Research has captured the maximum market share while the Research has the opportunity to emerge with the highest CAGR.

“Americas: The highest growing geography for the global immuno oncology assays market”

On the basis of geography, the global immuno oncology assays market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia). Among all these geography, the Asia-Pacific is showing the maximum growth in the near future with the highest CAGR while the Americas is dominating the market with highest market size.

“Agilent Technologies, Inc.: The potential growing player for the global immuno oncology assays market”

The key players profiled in the global immuno oncology assays market are Agilent Technologies, Inc., Foundation Medicine, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck, Nanostring Technologies, Inc., Perkinelmer, Qiagen, Roche Diagnostics, Sartorius AG, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global immuno oncology assays market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global immuno oncology assays market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global immuno oncology assays market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global immuno oncology assays market.
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global immuno oncology assays market.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Foundation Medicine
  • Illumina, Inc.
  • Merck
  • Perkinelmer
  • Qiagen
  • Roche Diagnostics
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting

3. Executive Summary

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing incidences of cancer
4.2.1.2. Adoption of targeted therapy over other treatment options
4.2.1.3. Development of bioinformatic tools enhancing the drug development process
4.2.1.4. Rise in healthcare expenditure and healthcare insurance
4.2.1.5. Technological advancement and R&D for the treatment of cancer
4.2.2. Restraints
4.2.2.1. Unfavorable regulatory and reimbursement scenario
4.2.3. Opportunities
4.2.3.1. Clinical trials to cure different cancers in immunotherapy
4.2.3.2. Companion diagnostics have the potential to improve immunotherapy efficacy and ensure greater safety
4.2.4. Challenges
4.2.4.1. Cancer limiting the immune response
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry

5. Market Data Feed
5.1. Introduction
5.2. Global Immuno Oncology Assays Market, by Indication
5.2.1. Bladder Cancer
5.2.2. Colorectal Cancer
5.2.3. Lung Cancer
5.2.4. Melanoma
5.3. Global Immuno Oncology Assays Market, by Product
5.3.1. Consumables
5.3.2. Software
5.4. Global Immuno Oncology Assays Market, by Technology
5.4.1. Flow Cytometry
5.4.2. Immunoassay
5.4.3. Ngs
5.4.4. PCR
5.5. Global Immuno Oncology Assays Market, by Application
5.5.1. Clinical Diagnostics
5.5.2. Research
5.6. Global Immuno Oncology Assays Market, by Geography

6. Americas Immuno Oncology Assays Market
6.1. Americas Immuno Oncology Assays Market, by Country
6.1.1. United States
6.1.2. Brazil
6.1.3. Canada
6.1.4. Mexico
6.1.5. Argentina
6.2. Americas Immuno Oncology Assays Market, by Indication
6.3. Americas Immuno Oncology Assays Market, by Product
6.4. Americas Immuno Oncology Assays Market, by Technology
6.5. Americas Immuno Oncology Assays Market, by Application

7. Europe, Middle East & Africa Immuno Oncology Assays Market
7.1. Europe, Middle East & Africa Immuno Oncology Assays Market, by Country
7.1.1. United Kingdom
7.1.2. Germany
7.1.3. France
7.1.4. Saudi Arabia
7.1.5. United Arab Emirates
7.1.6. Italy
7.1.7. Russia
7.2. Europe, Middle East & Africa Immuno Oncology Assays Market, by Indication
7.3. Europe, Middle East & Africa Immuno Oncology Assays Market, by Product
7.4. Europe, Middle East & Africa Immuno Oncology Assays Market, by Technology
7.5. Europe, Middle East & Africa Immuno Oncology Assays Market, by Application

8. Asia-Pacific Immuno Oncology Assays Market
8.1. Asia-Pacific Immuno Oncology Assays Market, by Country
8.1.1. China
8.1.2. Japan
8.1.3. India
8.1.4. Australia
8.2. Asia-Pacific Immuno Oncology Assays Market, by Indication
8.3. Asia-Pacific Immuno Oncology Assays Market, by Product
8.4. Asia-Pacific Immuno Oncology Assays Market, by Technology
8.5. Asia-Pacific Immuno Oncology Assays Market, by Application

9. Competitive Strategic Window
9.1. Introduction
9.1.1. Leverage Zone
9.1.2. Vantage Zone
9.1.3. Speculative Zone
9.1.4. Bottleneck Zone

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Introduction
10.1.2. Scores
10.1.2.1. Forefront
10.1.2.2. Pathfinders
10.1.2.3. Niche
10.1.2.4. Vital
10.1.3. Business Strategy
10.1.4. Product Satisfaction
10.2. Market Vendor Ranking Analysis
10.3. Competitive News Feed Analysis

11. Company Usability Profiles
11.1. Agilent Technologies, Inc.
11.2. Foundation Medicine
11.3. HTG Molecular Diagnostics, Inc.
11.4. Illumina, Inc.
11.5. Merck
11.6. Nanostring Technologies, Inc.
11.7. Perkinelmer
11.8. Qiagen
11.9. Roche Diagnostics
11.10. Sartorius AG
11.11. Thermo Fisher Scientific, Inc.

12. Appendix
12.1. Top Reports
12.2. Author Details

LIST OF TABLES

TABLE 1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD BILLION)
TABLE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD BILLION)
TABLE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 7. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2016 - 2024 (USD BILLION)
TABLE 8. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD BILLION)
TABLE 9. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD BILLION)
TABLE 10. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 11. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 12. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2016 - 2024 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD BILLION)
TABLE 14. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 16. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 17. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2016 - 2024 (USD BILLION)
TABLE 18. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD BILLION)
TABLE 19. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD BILLION)
TABLE 20. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 21. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 22. Scores FOR FOREFRONT IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 23. Scores FOR PATHFINDERS IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 24. Scores FOR NICHE IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 25. Scores FOR VITAL IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 26. FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 27. FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 28. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET RANKING, BY VENDORS, 2017

LIST OF FIGURES

FIGURE 1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. IMMUNO ONCOLOGY ASSAYS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD BILLION)
FIGURE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD BILLION)
FIGURE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD BILLION)
FIGURE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD BILLION)
FIGURE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD BILLION)
FIGURE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 17. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2017 VS 2024 (USD BILLION)
FIGURE 18. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD BILLION)
FIGURE 19. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD BILLION)
FIGURE 20. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD BILLION)
FIGURE 21. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD BILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2017 VS 2024 (USD BILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD BILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD BILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD BILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD BILLION)
FIGURE 27. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2017 VS 2024 (USD BILLION)
FIGURE 28. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD BILLION)
FIGURE 29. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD BILLION)
FIGURE 30. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD BILLION)
FIGURE 31. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD BILLION)
FIGURE 32. Competitive STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY INDICATION, 2024
FIGURE 33. Competitive STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2024
FIGURE 34. Competitive STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2024
FIGURE 35. Competitive STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2024
FIGURE 36. Competitive STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY GEOGRAPHY, 2024
FIGURE 37. FPNV POSITIONING MATRIX FOR IMMUNO ONCOLOGY ASSAYS MARKET
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Foundation Medicine
  • Illumina, Inc.
  • Merck
  • Perkinelmer
  • Qiagen
  • Roche Diagnostics
  • MORE
The global immuno oncology assays market is expected to grow at a Compound Annual Growth Rate (CAGR) of 11.95% from 2017 to 2024 to reach USD 5.43 billion.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The key chapters profiled in the report are as follows:1. Preface2. Research & Forecasting3. Executive Summary4. Premium Insight5. Market Data Feed6. Americas Immuno Oncology Assays Market7. Europe, Middle East & Africa Immuno Oncology Assays Market8. Asia-Pacific Immuno Oncology Assays Market9. Competitive Strategic Window10. Competitive Landscape11. Company Usability Profiles12. Appendix

The report answers questions such as:
1. What is the market size of immuno oncology assays market in the global?
2. What are the factors that affect the growth in global immuno oncology assays market over the forecast period?
3. What is the competitive position in the global immuno oncology assays market?
4. Which are the best product areas to be invested in over the forecast period?
5. What are the opportunities in the global immuno oncology assays market?
6. What are the modes of entering the global immuno oncology assays market?
Note: Product cover images may vary from those shown
5 of 5
  • Agilent Technologies, Inc.
  • Foundation Medicine
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Merck
  • Nanostring Technologies, Inc.
  • Perkinelmer
  • Qiagen
  • Roche Diagnostics
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4763781
Adroll
adroll